DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • October 6th, 2014 • Virobay Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 6th, 2014 Company Industry JurisdictionThis DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 4, 2012 (the “Effective Date”) by and between VIROBAY INC., a Delaware corporation with its principal place of business at 1490 O’Brien Drive, Suite G, Menlo Park, CA 94025, USA (“Virobay”), and LEO PHARMA A/S, a Danish private limited company with its principal place of business at 55, Industriparken, 2750 Ballerup, Denmark (“LEO”). Virobay and LEO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 11th, 2014 • Virobay Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2014 Company Industry JurisdictionThis DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 4, 2012 (the “Effective Date”) by and between VIROBAY INC., a Delaware corporation with its principal place of business at 1490 O’Brien Drive, Suite G, Menlo Park, CA 94025, USA (“Virobay”), and LEO PHARMA A/S, a Danish private limited company with its principal place of business at 55, Industriparken, 2750 Ballerup, Denmark (“LEO”). Virobay and LEO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.